The move is being made in light of both the impending loss of its U.S. Diovan (valsartan) patent in September and safety issues associated with combining the antihypertensive drug Rasilez/Tekturna (aliskiren) with angiotensin converting enzyme …
Xuchang Hengsheng Pharmaceutical Co., Ltd.
Manidipine Hydrochloride main manufacturer in the world